Tang Yanjing,Pan Ci,Xue Huiliang,Chen Jing,Dong Lu,Zhou Min,Ye Qidong,Shen Shuhong,Wang Yao-ping,Gu Longjun,Tang Jingyan . Outcome of children with low- or intermediate-risk neuroblastoma: a report of 70 cases[J]., 2014, 32(5): 413-416.
[1] Maris JM，Hogarty MD，Bagatell R，et al. Neuroblastoma [J]. Lancet，2007，369(9579)：2106-2120. [2] Ishola TA，Chung DH. Neuroblastoma. Surg Oncol [J]. 2007，16(3)：149-156. [3] 汤静燕，潘慈，陈静，等. 45例儿童神经母细胞瘤预后因素分析 [J]. 中华儿科杂志，2006，44（10）：770-773. [4] Brodeur GM，Seeger RC，Barrett A，et al. Revisions of the international criteria for neuroblastoma diagnosis，staging，and response to treatment [J]. J Clin Oncol，1993，11(8)：1466-1477. [5] ?ra I，Eggert A. Progress in treatment and risk stratification of neuroblastoma：impact on future clinical and basic research [J]. Semin Cancer Biol，2011，21(4)：217-228. [6] Cohn SL，Pearson AD，London WB，et al. The International Neuroblastoma Risk Group (INRG) classification system：an INRG Task Force report [J]. J Clin Oncol，2009，27(2)：289-297. [7] 汤静燕，潘慈，刘茵，等. 儿童Ⅳ期神经母细胞瘤远期随访报告 [J]. 中国小儿血液与肿瘤杂志，2009，14(2)：66-70. [8] 张广超，王景福. 国际神经母细胞瘤危险度分级（INRG）协作组最新共识 [J].中国肿瘤临床，2012，39(15)：1003-1007. [9] Kushner BH，Cheung NK. Treatment reduction for neuroblastoma [J]. Pediatr Blood Cancer，2004，43(6)：619-621. [10] Davidoff AM. Neuroblastoma [J]. Semin Pediatr Surg，2012，21(1)：2-14. [11] Baker DL，Schmidt ML，Cohn SL，et al. Outcome after reduced chemotherapy for intermediate-risk neuroblastoma [J]. N Engl J Med，2010，363(14)：1313-1323. [12] Strother DR，London WB，Schmidt ML，et al. Outcome after surgery alone or with restricted use of chemotherapy for patients with low-risk neuroblastoma：results of children’s oncology group study p9641 [J]. J Clin Oncol，2012，30(15)：1842-1848.
